Lamerz R - Search Results

1

Histologic, biochemical, and clinical parameters for monitoring multiple myeloma.

Bartl R, Frisch B, Diem H, Mündel M, Nagel D, Lamerz R, Fateh-Moghadam A. Bartl R, et al. Among authors: lamerz r. Cancer. 1991 Nov 15;68(10):2241-50. doi: 10.1002/1097-0142(19911115)68:10<2241::aid-cncr2820681024>3.0.co;2-0. Cancer. 1991. PMID: 1913461

2

Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M. Baur A, et al. Among authors: lamerz r. Cancer. 2002 Sep 15;95(6):1334-45. doi: 10.1002/cncr.10818. Cancer. 2002. PMID: 12216103 Free article.

3

Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.

Schambeck CM, Bartl R, Höchtlen-Vollmar W, Wick M, Lamerz R, Fateh-Moghadam A. Schambeck CM, et al. Among authors: lamerz r. Am J Clin Pathol. 1996 Jul;106(1):64-8. doi: 10.1093/ajcp/106.1.64. Am J Clin Pathol. 1996. PMID: 8701935

4

Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.

Schambeck CM, Wick M, Bartl R, Lamerz R, Fateh-Moghadam A. Schambeck CM, et al. Among authors: lamerz r. J Clin Pathol. 1995 May;48(5):477-81. doi: 10.1136/jcp.48.5.477. J Clin Pathol. 1995. PMID: 7629298 Free PMC article. Clinical Trial.

5

Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase.

Diem H, Fateh-Moghadam A, Lamerz R. Diem H, et al. Among authors: lamerz r. Clin Investig. 1993 Nov;71(11):918-23. doi: 10.1007/BF00185604. Clin Investig. 1993. PMID: 8312685

6

Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.

Stäbler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Stäbler A, et al. Among authors: lamerz r. AJR Am J Roentgenol. 1996 Oct;167(4):1029-36. doi: 10.2214/ajr.167.4.8819407. AJR Am J Roentgenol. 1996. PMID: 8819407

7

Light chain deposition disease in multiple myeloma: MR imaging features correlated with histopathological findings.

Baur A, Stäbler A, Lamerz R, Bartl R, Reiser M. Baur A, et al. Among authors: lamerz r. Skeletal Radiol. 1998 Mar;27(3):173-6. doi: 10.1007/s002560050360. Skeletal Radiol. 1998. PMID: 9554011

8

Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance.

Hoechtlen-Vollmar W, Menzel G, Bartl R, Lamerz R, Wick M, Seidel D. Hoechtlen-Vollmar W, et al. Among authors: lamerz r. Br J Haematol. 2000 Apr;109(1):30-8. doi: 10.1046/j.1365-2141.2000.02007.x. Br J Haematol. 2000. PMID: 10848779 Free article.

9

Prognostic role of methylated free circulating DNA in colorectal cancer.

Philipp AB, Stieber P, Nagel D, Neumann J, Spelsberg F, Jung A, Lamerz R, Herbst A, Kolligs FT. Philipp AB, et al. Among authors: lamerz r. Int J Cancer. 2012 Nov 15;131(10):2308-19. doi: 10.1002/ijc.27505. Epub 2012 Mar 27. Int J Cancer. 2012. PMID: 22362391

10

Serum marker combinations in human breast cancer (review).

Lamerz R, Stieber P, Fateh-Moghadam A. Lamerz R, et al. In Vivo. 1993 Nov-Dec;7(6B):607-13. In Vivo. 1993. PMID: 8193281 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters